{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:15:00Z","timestamp":1792224900034,"version":"4.4.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Treatment failure is considered to be an important factor in relation to the increase in scabies incidence over the last decade. However, the regional and temporal differences, in addition to the predictors of therapy failure, are unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to conduct a systematic review of the prevalence of treatment failure in patients with scabies and investigation of associated factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched MEDLINE, EMBASE, CINAHL, Web of Science, Scopus, Global Health and the Cochrane Central Register of Controlled Trials from inception to August 2021 for randomized and quasi-randomized trials, in addition to observational studies that enrolled children or adults diagnosed with confirmed or clinical scabies treated with permethrin, ivermectin, crotamiton, benzyl benzoate, malathion, sulfur or lindane, and measured treatment failure or factors associated with treatment failure. We performed a random effects meta-analysis for all outcomes reported by at least two studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 147 studies were eligible for inclusion in the systematic review. The overall prevalence of treatment failure was 15.2% [95% confidence interval (CI) 12.9\u201317.6; I2 = 95.3%, moderate-certainty evidence] with regional differences between World Health Organization regions (P = 0.003) being highest in the Western Pacific region (26.9%, 95% CI 14.5\u201341.2). Oral ivermectin (11.8%, 95% CI 8.4\u201315.4), topical ivermectin (9.3%, 95% CI 5.1\u201314.3) and permethrin (10.8%, 95% CI 7.5\u201314.5) had relatively lower failure prevalence compared with the overall prevalence. Failure prevalence was lower in patients treated with two doses of oral ivermectin (7.1%, 95% CI 3.1\u201312.3) compared with those treated with one dose (15.2%, 95% CI 10.8\u201320.2; P = 0.021). Overall and permethrin treatment failure prevalence in the included studies (1983\u20132021) increased by 0.27% and 0.58% per year, respectively. Only three studies conducted a multivariable risk factor analysis; no studies assessed resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A second dose of ivermectin showed lower failure prevalence than single-dose ivermectin, which should be considered in all guidelines. The increase in treatment failure over time hints at decreasing mite susceptibility for several drugs, but reasons for failure are rarely assessed. Ideally, scabicide susceptibility testing should be implemented in future studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljad308","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T23:56:25Z","timestamp":1693007785000},"page":"163-173","source":"Crossref","is-referenced-by-count":76,"title":["Failure of scabies treatment: a systematic review and\u00a0meta-analysis"],"prefix":"10.1093","volume":"190","author":[{"given":"Lawrence","family":"Mbuagbaw","sequence":"first","affiliation":[{"name":"Biostatistics Unit\/The Research Institute, St Joseph\u2019s Healthcare , Hamilton, ON , Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact"},{"name":"Department of Anesthesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Sadeghirad","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact"},{"name":"Department of Anesthesia"},{"name":"Michael G. DeGroote National Pain Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact"},{"name":"Evidence Foundation , Cleveland Heights, OH , USA"},{"name":"School of Medicine, Case Western Reserve University , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Mertz","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact"},{"name":"Department of Medicine, McMaster University , Hamilton, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Motaghi","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghadimi","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoluwa","family":"Babatunde","sequence":"additional","affiliation":[{"name":"Evidence Foundation , Cleveland Heights, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babalwa","family":"Zani","sequence":"additional","affiliation":[{"name":"Knowledge Translation Unit, University of Cape Town Lung Institute , Rondebosch , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejanth","family":"Pasumarthi","sequence":"additional","affiliation":[{"name":"Evidence Foundation , Cleveland Heights, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie","family":"Derby","sequence":"additional","affiliation":[{"name":"Evidence Foundation , Cleveland Heights, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata N","family":"Kothapudi","sequence":"additional","affiliation":[{"name":"Evidence Foundation , Cleveland Heights, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R","family":"Palmer","sequence":"additional","affiliation":[{"name":"Evidence Foundation , Cleveland Heights, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Aebischer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harder","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-3513","authenticated-orcid":false,"given":"Felix","family":"Reichert","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"2024012322595179300_ljad308-B1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.331.7517.619","article-title":"Scabies: diagnosis and treatment","volume":"331","author":"Johnston","year":"2005","journal-title":"BMJ"},{"key":"2024012322595179300_ljad308-B2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2024012322595179300_ljad308-B3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QCO.0b013e32835eb851","article-title":"Epidemiology of scabies","volume":"26","author":"Fuller","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"2024012322595179300_ljad308-B4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-0691.2012.03798.x","article-title":"Scabies in the developing world \u2013 its prevalence, complications, and management","volume":"18","author":"Hay","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2024012322595179300_ljad308-B5","doi-asserted-by":"crossref","first-page":"e2167","DOI":"10.1371\/journal.pntd.0002167","article-title":"Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies","volume":"7","author":"Engelman","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2024012322595179300_ljad308-B6","doi-asserted-by":"crossref","first-page":"190020","DOI":"10.2807\/1560-7917.ES.2019.24.23.190020","article-title":"Increase of scabies infestations, Norway, 2006 to 2018","volume":"24","author":"Amato","year":"2019","journal-title":"Euro Surveill"},{"key":"2024012322595179300_ljad308-B7","first-page":"264","article-title":"An increasing scabies incidence in Croatia: a call for coordinated action among dermatologists, physicians and epidemiologists","volume":"59","author":"Lugovi\u0107-Mihi\u0107","year":"2020","journal-title":"Zdr Varst"},{"key":"2024012322595179300_ljad308-B8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3201\/eid2706.203681","article-title":"Reemergence of scabies driven by adolescents and young adults, Germany, 2009\u20132018","volume":"27","author":"Reichert","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2024012322595179300_ljad308-B9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268865","article-title":"Increasing incidence of reported scabies infestations in the Netherlands, 2011\u20132021","volume":"17","author":"van Deursen","year":"2022","journal-title":"PLOS ONE"},{"key":"2024012322595179300_ljad308-B10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaad.2017.09.006","article-title":"Ivermectin versus permethrin in the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials","volume":"78","author":"Dhana","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2024012322595179300_ljad308-B11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.01.004","article-title":"Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials","volume":"80","author":"Thadanipon","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024012322595179300_ljad308-B12","article-title":"Ivermectin and permethrin for treating scabies","volume":"4","author":"Rosumeck","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2024012322595179300_ljad308-B13","first-page":"757","article-title":"The treatment of scabies: a systematic review of 25 randomized controlled trials","volume":"113","author":"Dressler","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"2024012322595179300_ljad308-B14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjd.17348","article-title":"Risk factors for treatment failure in scabies: a cohort study","volume":"180","author":"Aussy","year":"2019","journal-title":"Br J Dermatol"},{"key":"2024012322595179300_ljad308-B15","first-page":"874","article-title":"Risk factors for recurrence of scabies: a retrospective study of scabies patients in a long-term care hospital","volume":"38","author":"Makigami","year":"2011","journal-title":"J Dermatol"},{"key":"2024012322595179300_ljad308-B16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"2024012322595179300_ljad308-B17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"2024012322595179300_ljad308-B18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"2024012322595179300_ljad308-B19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"2024012322595179300_ljad308-B20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"2024012322595179300_ljad308-B21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2024012322595179300_ljad308-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008423","article-title":"A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambar\u00e9n\u00e9, Gabon","volume":"14","author":"Matthewman","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2024012322595179300_ljad308-B23","first-page":"15","article-title":"An open label, randomized, comparative study of antiscabietic drugs permethrin, gamma benzene hexachloride and ivermectin in patients of uncomplicated scabies","volume":"3","author":"Meenakshi","year":"2014","journal-title":"Int J Pharmacol Clin Sci"},{"issue":"4 Suppl.","key":"2024012322595179300_ljad308-B24","first-page":"162","article-title":"Mass drug administration strategies to control scabies in a highly endemic population","volume":"93","author":"Romani","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"2024012322595179300_ljad308-B25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0190-9622(86)70263-6","article-title":"Permethrin 5% dermal cream: a new treatment far scabies","volume":"15","author":"Taplin","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"2024012322595179300_ljad308-B26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.18369","article-title":"Ivermectin safety in infants and children under 15\u2005kg treated for scabies: a multicentric observational study","volume":"182","author":"Levy","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024012322595179300_ljad308-B27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0190-9622(83)70167-2","article-title":"Eradication of scabies with a single treatment schedule","volume":"9","author":"Taplin","year":"1983","journal-title":"J Am Adac Dermatol"},{"key":"2024012322595179300_ljad308-B28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjd.12454","article-title":"Treatment of scabies with oral ivermectin in 15 infants: a retrospective study on tolerance and efficacy","volume":"169","author":"B\u00e9court","year":"2013","journal-title":"Br J Dermatol"},{"key":"2024012322595179300_ljad308-B29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ijd.12353","article-title":"Scabies community prevalence and mass drug administration in two Fijian villages","volume":"53","author":"Haar","year":"2014","journal-title":"Int J Dermatol"},{"key":"2024012322595179300_ljad308-B30","first-page":"213","article-title":"[Comparative study of monosulfiram and benzyl benzoate in the treatment of scabies]","volume":"59","author":"Neto","year":"1984","journal-title":"An Bras Dermatol"},{"key":"2024012322595179300_ljad308-B31","first-page":"35","article-title":"Prevalence of scabies among school children in a rural block of coastal Karnataka","volume":"51","author":"Rotti","year":"1985","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2024012322595179300_ljad308-B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0190-9622(83)70168-4","article-title":"A comparative trial of three treatment schedules for the eradication of scabies","volume":"9","author":"Taplin","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"2024012322595179300_ljad308-B33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1610-0387.2006.05941.x","article-title":"Treatment of scabies with 5% permethrin cream: Results of a German multicenter study","volume":"4","author":"Hamm","year":"2006","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"2024012322595179300_ljad308-B34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1525-1470.1990.tb01078.x","article-title":"Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children","volume":"7","author":"Taplin","year":"1990","journal-title":"Pediatric Dermatology"},{"key":"2024012322595179300_ljad308-B35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(84)70157-5","article-title":"An epidemic of scabies with unusual features and treatment resistance in a nursing home","volume":"11","author":"Moberg","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"2024012322595179300_ljad308-B36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1757177417690920","article-title":"Scabies outbreak among healthcare workers in a German acute care hospital","volume":"18","author":"Leistner","year":"2017","journal-title":"J\u00a0Infect Prev"},{"key":"2024012322595179300_ljad308-B37","doi-asserted-by":"crossref","first-page":"M424","DOI":"10.1093\/gerona\/56.7.M424","article-title":"Atypical presentation of scabies among nursing home residents","volume":"56","author":"Wilson","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012322595179300_ljad308-B38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4103\/0378-6323.84063","article-title":"Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study","volume":"77","author":"Sharma","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2024012322595179300_ljad308-B39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10158-007-0050-6","article-title":"Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei","volume":"7","author":"Mounsey","year":"2007","journal-title":"Invert Neurosci"},{"key":"2024012322595179300_ljad308-B40","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1113\/JP275236","article-title":"Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin","volume":"596","author":"Chen","year":"2018","journal-title":"J Physiol"},{"key":"2024012322595179300_ljad308-B41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bjd.18517","article-title":"In vitro ovicidal activity of current and under-development scabicides: which treatments kill scabies eggs?","volume":"182","author":"Bernigaud","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024012322595179300_ljad308-B42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024012322595179300_ljad308-B43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/ddg.13130","article-title":"S1 guidelines on the diagnosis and treatment of scabies \u2013 short version","volume":"14","author":"Sunderk\u00f6tter","year":"2016","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"2024012322595179300_ljad308-B44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/1346-8138.13896","article-title":"Guideline for the diagnosis and treatment of scabies in Japan (third edition)","volume":"44","author":"Executive Committee of Guideline for the Diagnosis and Treatment of Scabies","year":"2017","journal-title":"J Dermatol"},{"key":"2024012322595179300_ljad308-B45","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1017\/S0950268816000443","article-title":"Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward","volume":"144","author":"Mounsey","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2024012322595179300_ljad308-B46","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei","volume":"39","author":"Currie","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2024012322595179300_ljad308-B47","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1111\/jdv.17538","article-title":"Scabies is becoming less sensitive to permethrin therapy","volume":"35","author":"Balestri","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024012322595179300_ljad308-B48","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1111\/jdv.18181","article-title":"European scabies challenge: what about permethrin-resistant mites?","volume":"36","author":"Mayer","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024012322595179300_ljad308-B49","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1111\/jdv.17339","article-title":"Is scabies becoming less sensitive to permethrin therapy?","volume":"35","author":"Mazzatenta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024012322595179300_ljad308-B50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005920","article-title":"Scabies in the age of increasing drug resistance","volume":"11","author":"Khalil","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2024012322595179300_ljad308-B51","doi-asserted-by":"crossref","first-page":"e15260","DOI":"10.1111\/dth.15260","article-title":"Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies","volume":"35","author":"Y\u00fcrekli","year":"2022","journal-title":"Dermatol Ther"},{"key":"2024012322595179300_ljad308-B52","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02334-17","article-title":"Efficacy and pharmacokinetics evaluation of a single oral dose of afoxolaner against Sarcoptes scabiei in the porcine scabies model for human infestation","volume":"62","author":"Bernigaud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024012322595179300_ljad308-B53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/14787210.2022.2099376","article-title":"Spinosad topical suspension (0.9%): a new topical treatment for scabies","volume":"20","author":"Fernando","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2024012322595179300_ljad308-B54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0035-9203(00)90454-1","article-title":"Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis","volume":"94","author":"Walton","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2024012322595179300_ljad308-B55","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1371\/journal.pntd.0000756","article-title":"A tractable experimental model for study of human and animal scabies","volume":"4","author":"Mounsey","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2024012322595179300_ljad308-B56","doi-asserted-by":"crossref","first-page":"O139","DOI":"10.1111\/1469-0691.12334","article-title":"Molecular survey of knockdown resistance to pyrethroids in human scabies mites","volume":"20","author":"Andriantsoanirina","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2024012322595179300_ljad308-B57","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmi.2015.08.002","article-title":"Sarcoptes scabiei mites in humans are distributed into three genetically distinct clades","volume":"21","author":"Andriantsoanirina","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2024012322595179300_ljad308-B58","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad308\/52137848\/ljad308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/2\/163\/56345151\/ljad308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/2\/163\/56345151\/ljad308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T23:08:57Z","timestamp":1706051337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/190\/2\/163\/7251446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8,25]]},"published-print":{"date-parts":[[2024,1,23]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad308","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,8,25]]}}}